The results revealed that RBAK functioned as an oncogene by inhibiting cell apoptosis of PCa cells, supporting the conclusion that miR-135a induced apoptosis of PCa cells, at least in part, by targeting and suppressing RBAK. The gene discussed is RBAK; the disease is posterior cortical atrophy.